XENETIC BIOSCIENCES, INC. Share-based Payment Arrangement, Expense
XENETIC BIOSCIENCES, INC. (XBIO) reported Share-based Payment Arrangement, Expense of $100.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-12
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $16.00K, a 42.86% decline year-over-year.
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $16.00K, a 61.90% decline year-over-year.
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $19.00K, a 75.32% decline year-over-year.
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2025 was $100.00K, a 50.00% decline from fiscal 2024.
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2024 was $200.00K, a 33.33% decline from fiscal 2023.
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2023 was $300.00K, a 40.00% decline from fiscal 2022.
- XENETIC BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2022 was $500.00K, a 25.00% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $16.00K derived: sum of 2 quarters · filed 2026-03-12 | $32.00K derived: sum of 3 quarters · filed 2026-03-12 | $100.00K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $16.00K 10-Q · filed 2025-11-12 | $32.00K derived: sum of 2 quarters · filed 2025-11-12 | $100.00K 10-Q · filed 2025-11-12 | $151.00K derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2025-06-30 | $16.00K 10-Q · filed 2025-08-12 | $35.00K 10-Q · filed 2025-08-12 | $135.00K derived: sum of 3 quarters · filed 2026-03-12 | $163.00K derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2025-03-31 | $19.00K 10-Q · filed 2025-05-13 | $119.00K derived: sum of 2 quarters · filed 2026-03-12 | $147.00K derived: sum of 3 quarters · filed 2026-03-12 | $189.00K derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $128.00K derived: sum of 2 quarters · filed 2026-03-12 | $170.00K derived: sum of 3 quarters · filed 2026-03-12 | $200.00K 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $28.00K 10-Q · filed 2025-11-12 | $70.00K derived: sum of 2 quarters · filed 2025-11-12 | $100.00K 10-Q · filed 2025-11-12 | $146.71K 10-Q · filed 2024-11-12 | $238.49K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $42.00K 10-Q · filed 2025-08-12 | $100.00K 10-Q · filed 2025-08-12 | $210.49K derived: sum of 3 quarters · filed 2025-08-12 | $310.49K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $77.00K 10-Q · filed 2025-05-13 | $100.00K 10-Q · filed 2024-05-09 | $168.49K derived: sum of 2 quarters · filed 2025-05-13 | $268.49K derived: sum of 3 quarters · filed 2025-05-13 | $368.49K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $91.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $191.49K derived: sum of 2 quarters · filed 2025-03-18 | $291.49K derived: sum of 3 quarters · filed 2025-03-18 | $300.00K 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $208.51K 10-Q · filed 2024-11-12 | $200.00K 10-Q · filed 2023-11-09 | $400.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-10 | $100.00K 10-Q · filed 2023-08-10 | $300.00K derived: sum of 3 quarters · filed 2024-05-09 | $400.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | $200.00K derived: sum of 2 quarters · filed 2024-05-09 | $300.00K derived: sum of 3 quarters · filed 2024-05-09 | $400.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $200.00K derived: sum of 2 quarters · filed 2024-03-21 | $300.00K derived: sum of 3 quarters · filed 2024-03-21 | $500.00K 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $400.00K 10-Q · filed 2023-11-09 | $400.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $300.00K 10-Q · filed 2023-08-10 | $300.00K derived: sum of 3 quarters · filed 2023-08-10 | $400.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-11 | $200.00K derived: sum of 2 quarters · filed 2023-05-11 | $300.00K derived: sum of 3 quarters · filed 2023-05-11 | $400.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $200.00K derived: sum of 2 quarters · filed 2023-03-22 | $300.00K derived: sum of 3 quarters · filed 2023-03-22 | $400.00K 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-09 | $111.13K 10-Q · filed 2021-11-12 | $200.00K derived: sum of 2 quarters · filed 2022-11-09 | $300.00K 10-Q · filed 2022-11-09 | $297.34K 10-Q · filed 2021-11-12 | $411.87K derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-11 | $109.92K 10-Q · filed 2021-08-12 | $200.00K 10-Q · filed 2022-08-11 | $186.21K 10-Q · filed 2021-08-12 | $311.87K derived: sum of 3 quarters · filed 2022-08-11 | $422.67K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-12 | $76.28K 10-Q · filed 2021-05-11 | $211.87K derived: sum of 2 quarters · filed 2022-05-12 | $322.67K derived: sum of 3 quarters · filed 2022-05-12 | $434.40K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $111.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $222.67K derived: sum of 2 quarters · filed 2022-03-22 | $334.40K derived: sum of 3 quarters · filed 2022-03-22 | $500.00K 10-K · filed 2022-03-22 | $468.91K 10-K · filed 2021-03-16 | |||
| 2020-09-30 | $110.80K 10-Q · filed 2021-11-12 | $222.53K derived: sum of 2 quarters · filed 2021-11-12 | $388.13K 10-Q · filed 2021-11-12 | $511.12K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $111.73K 10-Q · filed 2021-08-12 | $277.33K 10-Q · filed 2021-08-12 | $400.32K derived: sum of 3 quarters · filed 2021-08-12 | $647.75K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $165.60K 10-Q · filed 2021-05-11 | $288.58K derived: sum of 2 quarters · filed 2021-05-11 | $536.02K derived: sum of 3 quarters · filed 2021-05-11 | $785.17K derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $122.99K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $370.42K derived: sum of 2 quarters · filed 2021-03-16 | $619.58K derived: sum of 3 quarters · filed 2021-03-16 | $853.52K 10-K · filed 2021-03-16 | ||||
| 2019-09-30 | $247.44K 10-Q · filed 2020-11-12 | $496.59K derived: sum of 2 quarters · filed 2020-11-12 | $730.53K 10-Q · filed 2020-11-12 | $987.04K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $249.15K 10-Q · filed 2020-08-12 | $483.09K 10-Q · filed 2020-08-12 | $739.60K derived: sum of 3 quarters · filed 2020-08-12 | $1.06M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $233.94K 10-Q · filed 2020-05-14 | $490.45K derived: sum of 2 quarters · filed 2020-05-14 | $813.92K derived: sum of 3 quarters · filed 2020-05-14 | $1.26M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $256.51K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $579.98K derived: sum of 2 quarters · filed 2020-03-26 | $1.03M derived: sum of 3 quarters · filed 2020-03-26 | $1.43M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $323.48K 10-Q · filed 2019-11-14 | $769.09K derived: sum of 2 quarters · filed 2019-11-14 | $1.18M 10-Q · filed 2019-11-14 | $1.48M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $445.61K 10-Q · filed 2019-08-14 | $851.80K 10-Q · filed 2019-08-14 | $1.15M derived: sum of 3 quarters · filed 2019-08-14 | $1.46M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $406.19K 10-Q · filed 2019-05-13 | $707.43K derived: sum of 2 quarters · filed 2019-05-13 | $1.01M derived: sum of 3 quarters · filed 2019-05-13 | $1.53M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $301.24K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $603.23K derived: sum of 2 quarters · filed 2019-03-29 | $1.13M derived: sum of 3 quarters · filed 2019-03-29 | $1.79M 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | $301.99K 10-Q · filed 2018-11-09 | $825.86K derived: sum of 2 quarters · filed 2018-11-09 | $1.49M 10-Q · filed 2018-11-09 | $2.08M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $523.87K 10-Q · filed 2018-08-10 | $1.19M 10-Q · filed 2018-08-10 | $1.78M derived: sum of 3 quarters · filed 2018-08-10 | $2.40M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $666.00K 10-Q · filed 2018-05-15 | $1.26M derived: sum of 2 quarters · filed 2018-05-15 | $1.87M derived: sum of 3 quarters · filed 2018-05-15 | $3.60M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $589.46K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $1.21M derived: sum of 2 quarters · filed 2018-03-30 | $2.94M derived: sum of 3 quarters · filed 2018-03-30 | $3.22M 10-K · filed 2018-03-30 | ||||
| 2016-09-30 | $616.93K 10-Q · filed 2017-11-14 | $2.35M derived: sum of 2 quarters · filed 2017-11-14 | $2.64M 10-Q · filed 2017-11-14 | $2.93M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $1.73M 10-Q · filed 2017-08-14 | $2.02M 10-Q · filed 2017-08-14 | $2.32M derived: sum of 3 quarters · filed 2017-08-14 | $4.38M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $286.46K 10-Q · filed 2017-05-15 | $585.86K derived: sum of 2 quarters · filed 2017-05-15 | $2.64M derived: sum of 3 quarters · filed 2017-05-15 | $2.73M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $299.40K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $2.36M derived: sum of 2 quarters · filed 2017-03-31 | $2.45M derived: sum of 3 quarters · filed 2017-03-31 | $2.59M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | $2.06M 10-Q · filed 2016-11-14 | $2.15M derived: sum of 2 quarters · filed 2016-11-14 | $2.29M 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $89.97K 10-Q · filed 2016-08-15 | $238.20K 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | $147.23K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |